Clenbuterol, a β2-adrenoceptor agonist, reduces scoliosis due to partial transection of rat spinal cord

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 4 35-4, 1997, Pages

  Zeman, Richard J ^a   Zhang, Yan ^a   Etlinger, Joseph D ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

contractility; loading; paraspinal muscle; spinal cord injury; vertebra

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BRACE; DRUG EFFECT; ELECTROSTIMULATION; MUSCLE CONTRACTILITY; MUSCLE TONE; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; RAT; SCOLIOSIS; SPINAL CORD INJURY; SPINAL CORD TRANSSECTION; ANIMAL; BACK; DENERVATION; FEMALE; RADIOGRAPHY; THORAX; WISTAR RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; CLENBUTEROL; DENERVATION; FEMALE; LUMBOSACRAL REGION; RATS; RATS, WISTAR; SCOLIOSIS; SPINAL CORD INJURIES; THORAX;

EID: 0031114948     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.4.e712     Document Type: Article

References (28)

1. Agbenyega, E. T., and A. C. Wareham. Effect of clenbuterol on normal and denervated muscle growth and contractility. Muscle Nerve 13: 199-203, 1990.
2. Barrios, C., M. T. Tunon, J. A. DeSalis, J. L. Beguiristain, and J. Canadell. Scoliosis induced by medullary damage: an experimental study in rabbits. Spine 12: 433-439, 1987.
3. Beals, R. K. Nosologic and genetic aspects of scoliosis. Clin. Orthop. Relat. Res. 93: 23-32, 1973.
4. Bowman, W. C. Effects of adrenergic activators and inhibitors on the skeletal muscles. In: Handbook of Experimental Pharmacology, edited by L. Serkeres. Heidelberg, Germany: Springer-Verlag, 1980, vol. 54, p. 47-128.
5. D'Ambrosia, R. D. (Editor). Musculoskeletal Disorders: Regional Examination and Differential Diagnosis. Philadelphia, PA: Lippincott, 1986, p. 345-351.
6. Dearolf, W. W., III, R. R. Betz, L. C. Vogel, J. Levin, M. Clancy, and H. H. Steel. Scoliosis in pediatric spinal cord-injured patients. J. Pediatr. Orthop. 10: 214-218, 1990.
7. Follesa, P., and I. Mocchetti. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by β-adrenergic receptor activation and adrenal steroids in rat central nervous system. Mol. Pharmacol. 43: 132-137, 1992.
8. Galasko, C. S. B., and C. M. Delaney. Severity of scoliosis in patients with Duchenne muscular dystrophy at the time of referral to an orthopedic clinic. Muscle Nerve 16: 433-434, 1993.
9. Ghista, D. N., G. R. Viviani, K. Subbaraj, P. J. Lozada, T. M. Srinivasan, and G. Barnes. Biomechanical basis of optimal scoliosis surgical correction. J. Biomech. 21: 77-88, 1988.
10. Kasamatsu, T., and T. Shirokawa. Involvement of beta-adrenoreceptors in the shift of ocular dominance after monocular deprivation. Exp. Brain Res. 59: 507-514, 1985.
11. Kennelly, K. P., and M. J. Stokes. Pattern of asymmetry of paraspinal muscle size in adolescent idiopathic scoliosis examined by real-time ultrasound imaging: a preliminary study. Spine 18: 913-917, 1993.
12. Kwon, J., S. Farrell, M. Downen, E. Eves, and B. H. Wainer. Forskolin and adrenergic agonist-induced cytoskeletal changes in a basal forebrain cell line. Soc. Neurosci. Abstr. 20: 241, 1994.
13. Little, J. W., R. M. Harris, and R. C. Sohlberg. Locomotor recovery following subtotal spinal cord lesions in a rat model. Neurosci. Lett. 87: 189-194, 1988.
14. Macintosh, J. E., F. Valencia, N. Bogduk, and R. R. Munro. The morphology of the lumbar multifidus. Clin. Biomech. 1: 196-204, 1986.
15. Maguire, J., R. Madigan, S. Wallace, R. Leppanen, and V. Draper. Intraoperative long-latency reflex activity in idiopathic scoliosis demonstrates abnormal central processing: a possible cause of idiopathic scoliosis. Spine 18: 1621-1626, 1993.
16. Maltin, C. A., M. I. Delday, J. S. Watson, S. D. Keys, I. M. Nevison, I. K. Ritchie, and P. H. Gibson. Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin. Sci. Lond. 84: 651-654, 1993.
17. Pincott, J. R., J. S. Davies, and L. F. Taffs. Scoliosis caused by section of dorsal spinal nerve roots. J. Bone Jt. Surg. Br. Vol. 66B: 27-29, 1984.
18. Pincott, J. R., and L. F. Taffs. Experimental scoliosis in primates. J. Bone Jt. Surg. Br. Vol. 64B: 503-507, 1982.
19. Reeds, P. J., S. M. Hay, P. M. Dorwood, and R. M. Palmer. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br. J. Nutr. 56: 249-258, 1986.
20. Schultz, A., K. Haderspeck, and S. Takashima. Correction of scoliosis by muscle stimulation: biomechanical analyses. Spine 6: 468-476, 1981.
21. Suk, S. I., H. S. Song, and C. K. Lee. Scoliosis induced by anterior and posterior rhizotomy. Spine 14: 692-697, 1989.
22. Takashima, S. T., S. P. Singh, K. A. Haderspeck, and A. B. Schultz. A model for semi-quantitative studies of muscle actions. J. Biomechanics 12: 929-939, 1979.
23. Williams, J. H., and W. S. Barnes. The positive inotropic effect of epinephrine on skeletal muscle: a brief review. Muscle Nerve 12: 968-975, 1989.
24. Zaimis, E. Spasticity alleviation by drugs acting directly on skeletal muscle. Lancet I: 403-405, 1973.
25. 2-receptor agonist, reduces net bone loss in denervated hindlimbs. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E285-E289, 1991.
26. 2-receptor agonist. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E726-E732, 1988.
27. Zeman, R. J., R. Ludemann, and J. D. Etlinger. Clenbuterol, a β2-agonist, retards atrophy in denervated muscles. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E152-E155, 1987.
28. 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 267 (Cell Physiol. 36): C865-C868, 1994.